WATCHMAKER GENOMICS LIMITED
Get an alert when WATCHMAKER GENOMICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-26 (in 5mo)
Last made up 2025-10-12
Watchouts
None on the register
Cash
£506K
+161.4% vs 2023
Net assets
-£403K
+26.1% vs 2023
Employees
2
0% vs 2023
Profit before tax
£12K
+103.5% vs 2023
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £280,831 | £812,783 | |
| Operating profit | -£336,017 | £32,512 | |
| Profit before tax | -£356,521 | £12,377 | |
| Net profit | -£356,521 | £142,299 | |
| Cash | £193,501 | £505,786 | |
| Total assets less current liabilities | -£232,984 | -£85,416 | |
| Net assets | -£545,182 | -£402,883 | |
| Equity | -£545,182 | -£402,883 | |
| Average employees | 2 | 2 | |
| Wages | £246,901 | £306,213 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -119.7% | 4.0% | |
| Net margin | -127.0% | 17.5% | |
| Return on capital employed | 144.2% | -38.1% | |
| Gearing (liabilities / total assets) | 272.7% | 147.2% | |
| Current ratio | 0.57x | 0.77x | |
| Interest cover | -16.38x | 1.61x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“We draw attention to the fact that at 31 December 2024, the company had accumulated losses of £ 402,893 and that the company's total liabilities exceed its total assets by £ 402,883. The directors believe that the company has adequate financial resources to continue in operation for the foreseeable future and accordingly the annual report and financial statements have been prepared on a going concern basis. The directors have satisfied themselves that the company is in a sound financial position and that it has access to sufficient borrowing facilities to meet its foreseeable cash requirements. These borrowing facilities will be made available, if required, by its parent and the directors have received a letter of support form the parent company to that effect.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LIU, Jingzi | Secretary | 2021-10-13 | — | — |
| DENEAU, Brian H | Director | 2021-10-13 | May 1974 | American |
| FOSKETT, John Ferguson | Director | 2021-10-13 | Mar 1974 | American |
| LIU, Jingzi | Director | 2021-10-13 | May 1977 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Watchmaker Genomics Inc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-10-13 | Ceased 2022-10-18 |
| Mr Andrew Richard Beaumont | Individual | Shares 75–100% | 2021-10-13 | Ceased 2021-10-13 |
Filing timeline
Last 14 of 14 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-02 | AA | accounts | Accounts with accounts type full | |
| 2024-10-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-11 | AA | accounts | Accounts with accounts type full | |
| 2023-10-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-24 | AA | accounts | Accounts with accounts type full | |
| 2022-10-21 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2022-10-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-10-19 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-03-21 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-02-25 | AA01 | accounts | Change account reference date company current extended | |
| 2021-10-15 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2021-10-15 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2021-10-13 | NEWINC | incorporation | Incorporation company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+189.4%
£280,831 £812,783
-
Cash
+161.4%
£193,501 £505,786
-
Net assets
+26.1%
-£545,182 -£402,883
-
Employees
0%
2 2
-
Operating profit
+109.7%
-£336,017 £32,512
-
Profit before tax
+103.5%
-£356,521 £12,377
-
Wages
+24%
£246,901 £306,213
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers